High-content imaging for automated determination of host-cell infection rate by the intracellular parasite Trypanosoma cruzi

Parasitology International

Volumn 59, Issue 4, 2010, Pages 565-570

  Nohara, L L ^a   Lema, C ^a   Bader, J O ^a   Aguilera, R J ^a   Almeida, I C ^a  

^a UNIVERSITY OF TEXAS AT EL PASO   (United States)

Author keywords

Chagas disease; High content imaging; Host cell infection rate; Intracellular parasite; Trypanosoma cruzi

Indexed keywords

ANIMAL CELL; ARTICLE; AUTOMATED HIGH CONTENT IMAGIN; CHAGAS DISEASE; HOST CELL; IMAGE ANALYSIS; IN VITRO STUDY; MOLECULAR IMAGING; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ANIMALS; AUTOMATION; FIBROBLASTS; GREEN FLUORESCENT PROTEINS; HOST-PARASITE INTERACTIONS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LINEAR MODELS; MICE; NIH 3T3 CELLS; SOFTWARE; TRYPANOSOMA CRUZI;

TRYPANOSOMA CRUZI;

EID: 77958509445     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parint.2010.07.007     Document Type: Article

References (38)

1. Chagas C. Nova tripanosomiase humana. Estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi, n.g., n. Sp., ajente etiolójico de nova entidade morbida do homem. Mem Inst Oswaldo Cruz 1909, 1:159-218.
2. Schmunis G.A. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz 2007, 102(Suppl 1):75-85.
3. Bern C., Montgomery S.P. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 2009, 49:e52-e54.
4. Bradley K.K., Bergman D.K., Woods J.P., Crutcher J.M., Kirchhoff L.V. Prevalence of American trypanosomiasis (Chagas disease) among dogs in Oklahoma. J Am Vet Med Assoc 2000, 217:1853-1857.
5. Pung O.J., Banks C.W., Jones D.N., Krissinger M.W. Trypanosoma cruzi in wild raccoons, opossums, and triatomine bugs in southeast Georgia, U.S.A. J Parasitol 1995, 81:324-326.
6. Reisenman C.E., Lawrence G., Guerenstein P.G., Gregory T., Dotson E., Hildebrand J.G. Infection of kissing bugs with Trypanosoma cruzi, Tucson, Arizona, USA. Emerg Infect Dis 2010, 16:400-405.
7. Herwaldt B.L., Grijalva M.J., Newsome A.L., McGhee C.R., Powell M.R., Nemec D.G., et al. Use of polymerase chain reaction to diagnose the fifth reported US case of autochthonous transmission of Trypanosoma cruzi, in Tennessee, 1998. J Infect Dis 2000, 181:395-399.
8. Bern C., Montgomery S.P., Katz L., Caglioti S., Stramer S.L. Chagas disease and the US blood supply. Curr Opin Infect Dis 2008, 21:476-482.
9. Bowling J., Walter E.A. Recognizing and meeting the challenge of Chagas disease in the USA. Expert Rev Anti Infect Ther 2009, 7:1223-1234.
10. Lauria-Pires L., Braga M.S., Vexenat A.C., Nitz N., Simoes-Barbosa A., Tinoco D.L., et al. Progressive chronic Chagas heart disease ten years after treatment with anti-Trypanosoma cruzi nitroderivatives. Am J Trop Med Hyg 2000, 63:111-118.
11. Croft S.L., Barrett M.P., Urbina J.A. Chemotherapy of trypanosomiases and leishmaniasis. Trends Parasitol 2005, 21:508-512.
12. Tarleton R.L., Reithinger R., Urbina J.A., Kitron U., Gurtler R.E. The challenges of Chagas Disease-grim outlook or glimmer of hope. PLoS Med 2007, 4:e332.
13. Rodriques Coura J., de Castro S.L. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 2002, 97:3-24.
14. Buckner F.S., Wilson A.J., White T.C., Van Voorhis W.C. Induction of resistance to azole drugs in Trypanosoma cruzi. Antimicrob Agents Chemother 1998, 42:3245-3250.
15. Tyler K.M., Engman D.M. The life cycle of Trypanosoma cruzi revisited. Int J Parasitol 2001, 31:472-481.
16. Barrias E.S., Reignault L.C., De Souza W., Carvalho T.M. Dynasore, a dynamin inhibitor, inhibits Trypanosoma cruzi entry into peritoneal macrophages. PLoS One 2010, 5:e7764.
17. Hoff R. Killing in vitro of Trypanosoma cruzi by macrophages from mice immunized with T. cruzi or BCG, and absence of cross-immunity on challenge in vivo. J Exp Med 1975, 142:299-311.
18. Woolsey A.M., Burleigh B.A. Host cell actin polymerization is required for cellular retention of Trypanosoma cruzi and early association with endosomal/lysosomal compartments. Cell Microbiol 2004, 6:829-838.
19. Andrade L.O., Andrews N.W. Lysosomal fusion is essential for the retention of Trypanosoma cruzi inside host cells. J Exp Med 2004, 200:1135-1143.
20. Rowland E.C., Moore-Lai D., Seed J.R., Stephens C.E., Boykin D.W. Inhibition of in vitro intracellular growth of Trypanosoma cruzi by dicationic compounds. J Parasitol 2003, 89:1078-1080.
21. Buckner F.S., Verlinde C.L., La Flamme A.C., Van Voorhis W.C. Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase. Antimicrob Agents Chemother 1996, 40:2592-2597.
22. Yan W., Moreno S.N. A method to assess invasion and intracellular replication of Trypanosoma cruzi based on differential uracil incorporation. J Immunol Methods 1998, 220:123-128.
23. Hyland K.V., Asfaw S.H., Olson C.L., Daniels M.D., Engman D.M. Bioluminescent imaging of Trypanosoma cruzi infection. Int J Parasitol 2008, 38:1391-1400.
24. Mezencev R., Galizzi M., Kutschy P., Docampo R. Trypanosoma cruzi: antiproliferative effect of indole phytoalexins on intracellular amastigotes in vitro. Exp Parasitol 2009, 122:66-69.
25. Kraus J.M., Verlinde C.L., Karimi M., Lepesheva G.I., Gelb M.H., Buckner F.S. Rational modification of a candidate cancer drug for use against Chagas disease. J Med Chem 2009, 52:1639-1647.
26. Zanella F., Lorens J.B., Link W. High content screening: seeing is believing. Trends Biotechnol 2010.
27. Link W., Oyarzabal J., Serelde B.G., Albarran M.I., Rabal O., Cebria A., Alfonso P., et al. Chemical interrogation of FOXO3a nuclear translocation identifies potent and selective inhibitors of phosphoinositide 3-kinases. J Biol Chem 2009, 284:28392-28400.
28. Agler M., Prack M., Zhu Y., Kolb J., Nowak K., Ryseck R., et al. A high-content glucocorticoid receptor translocation assay for compound mechanism-of-action evaluation. J Biomol Screen 2007, 12:1029-1041.
29. Ross D.A., Lee S., Reiser V., Xue J., Alves K., Vaidya S., et al. Multiplexed assays by high-content imaging for assessment of GPCR activity. J Biomol Screen 2008, 13:449-455.
30. De Rycker M., Rigoreau L., Dowding S., Parker P.J. A high-content, cell-based screen identifies micropolyin, a new inhibitor of microtubule dynamics. Chem Biol Drug Des 2009, 73:599-610.
31. Conrad C., Gerlich D.W. Automated microscopy for high-content RNAi screening. J Cell Biol 2010, 188:453-461.
32. Kuijl C., Savage N.D., Marsman M., Tuin A.W., Janssen L., Egan D.A., et al. Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1. Nature 2007, 450:725-730.
33. Engel J.C., Ang K.K., Chen S., Arkin M.R., McKerrow J.H., Doyle P.S. Image-based high throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease. Antimicrob Agents Chemother 2010.
34. Andrews N.W., Colli W. Adhesion and interiorization of Trypanosoma cruzi in mammalian cells. J Protozool 1982, 29:264-269.
35. Uphoff C.C., Drexler H.G. Detection of mycoplasma contaminations. Methods Mol Biol 2005, 290:13-23.
36. Burleigh B.A., Woolsey A.M. Cell signalling and Trypanosoma cruzi invasion. Cell Microbiol 2002, 4:701-711.
37. Andrade L.O., Andrews N.W. The Trypanosoma cruzi-host-cell interplay: location, invasion, retention. Nat Rev Microbiol 2005, 3:819-823.
38. Ley V., Andrews N.W., Robbins E.S., Nussenzweig V. Amastigotes of Trypanosoma cruzi sustain an infective cycle in mammalian cells. J Exp Med 1988, 168:649-659.